Surgical Wire Recalled After Ninth Australian Child With Piece In Chest
This article was originally published in PharmAsia News
Executive Summary
The Australian hospital sponsor of surgical wires made by U.S.-based Arrow International has recalled the devices after pieces of them were found in a ninth child. Mayo Healthcare, the sponsor recalled the peripheral inserted central catheter lines that used the wires to guide the device into place for injecting chemotherapy drugs and antibiotics into children in Queensland. The Therapeutic Goods Administration is investigating other PICC brands as well. A Mayo Healthcare executive emphasized the problem was human error and the wire device itself was not defective. (Click here for more
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.